Oral budesonide for induction of remission in ulcerative colitis-Reference-Cited by-同舟云学术

Oral budesonide for induction of remission in ulcerative colitis

Published:2015-10-26 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Sherlock Mary E¹,MacDonald John K²,Griffiths Anne Marie³,Steinhart A Hillary⁴,Seow Cynthia H⁵

Affiliation:

1. McMaster Children's Hospital; Division of Gastroenterology & Nutrition; Hamilton Health Sciences 1280 Main Street West Hamilton ON Canada

2. Robarts Research Institute; Robarts Clinical Trials; P.O. Box 5015 100 Perth Drive London ON Canada N6A 5K8

3. The Hospital for Sick Children; Division of Gastroenterology, Hepatology & Nutrition; 555 University Ave. Toronto ON Canada M5G 1X8

4. Mount Sinai Hospital; Department of Medicine, Division of Gastroenterology; Room 445, 600 University Avenue Toronto ON Canada M5G 1X5

5. University of Calgary; Department of Medicine; TRW Building Rm 6D18 3280 Hospital Drive NW Calgary AB Canada T2N 4Z6

Publisher

Wiley

Subject

Pharmacology (medical)

Reference93 articles.

1. Safety and efficacy of a novel extended release budesonide formulation in patients with active left-sided ulcerative colitis;D'Haens;Gastroenterology,2007

2. Clinical trial: Preliminary efficacy and safety study of a new budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis;D'Haens;Journal of Crohn's and Colitis,2010

3. 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial;Gross;Journal of Crohn's and Colitis,2011

4. Efficacy and tolerability of a once daily treatment with budesonide capsules versus mesalamine granules for the treatment of active ulcerative colitis: A randomized, double-blind, double-dummy, multicenter study;Gross;Gastroenterology,2009

5. Oral budesonide versus prednisone in patients with active extensive and left-sided ulcerative colitis;Löfberg;Gastroenterology,1996

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Budesonide in Liver Immunology: A Therapeutic Opportunity in Liver Transplantation;Current Transplantation Reports;2024-07-11

2. Outcomes of Budesonide as a Treatment Option for Immune Checkpoint Inhibitor-Related Colitis in Patients with Cancer;Cancers;2024-05-18

3. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2);Zeitschrift für Gastroenterologie;2024-05

4. Update for surgeons on novel induction treatments for acute severe inflammatory bowel disease associated colitis;ANZ Journal of Surgery;2024-03-07

5. Management and treatment optimization of patients with mild to moderate ulcerative colitis;Expert Review of Clinical Immunology;2023-12-07